Billionaire T. Boone Pickens’ New Stock Picks Include FCX

The 13F reported a new position of a little over 60,000 shares of oil major Occidental Petroleum Corporation (NYSE:OXY). Occidental made our list of the most popular energy stocks among hedge funds for the fourth quarter of 2012 (see more energy stocks hedge funds loved). It too has been impacted by lower margins, with earnings down sharply in Q4 from their levels in the same period in the previous year even though sales actually increased slightly. The stock carries trailing and forward P/E multiples of 14 and 10, respectively- this makes it at least as expensive as market leader Exxon Mobil Corporation (NYSE:XOM).

Weatherford International Ltd (NYSE:WFT), a $9.1 billion market cap oil and gas equipment and services company, was another of Pickens’ new stock picks. Because much of the demand for equipment is tied to drilling activity, Weatherford’s stock price is sensitive to market conditions with a beta of 2.2. However, it has fallen 28% against a rising market in the last year as earnings have tumbled. Consensus for 2013 places the current-year P/E at 12. Billionaire Jeffrey Vinik was also buying Weatherford shares between October and December (research more stocks Vinik owned).

One company which is moving into the oil business through a pair of related acquisitions is Freeport-McMoRan Copper & Gold Inc. (NYSE:FCX), and that stock was the fifth largest new holding for Pickens. The market has reacted quite negatively to the acquisition news- in addition to Freeport-McMoRan being treasured as a barometer of copper demand, the acquisitions came at large premiums to where the target companies had been trading. While we didn’t like the deal it’s possible the market has driven down the stock price to value levels. Billionaire John Paulson’s Paulson & Co. reported a large position in Freeport-McMoRan at the end of December (find more stocks Paulson was buying).

Disclosure: I own no shares of any stocks mentioned in this article.

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!